Artelo Biosciences, Inc. (ARTL) Technical Analysis & Indicators

Artelo Biosciences, Inc. (ARTL) — Price $3.75 HealthcareBiotechnology — NASDAQ

Latest reported results:

Technical analysis of Artelo Biosciences, Inc. (ARTL): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust developmental portfolio encompasses several promising candidates: ART27.13, a synthetic G protein-coupled receptor agonist currently undergoing Phase 1b/2a clinical investigation for cancer-related anorexia; ART12.11, a synthetic cannabidiol cocrystal being explored for inflammatory...

Price Performance

1 month-42.92%
3 months-66.93%
Year-to-date-65.85%
1 year-91.51%
3 years-95.31%
5 years-99.46%

52-Week Range

52-week High$179.19
52-week Low$3.45
Avg Volume (90d)117K

Technical Indicators

SMA 50$7.27
SMA 200$20.93
Beta0.41
30-day Volatility (annualised)121.7%
Price vs SMA 50-48.4%
Price vs SMA 200-82.1%

Monthly Close (12 months)

MonthCloseChange
2025-10$27.90
2025-11$15.66-43.9%
2025-12$10.98-29.9%
2026-01$15.39+40.2%
2026-02$32.13+108.8%
2026-03$68.22+112.3%
2026-04$31.41-54.0%
2026-05$12.60-59.9%
2026-06$10.08-20.0%
2026-07$6.93-31.3%
2026-08$6.36-8.2%
2026-09$3.75-41.0%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-09-14$-2.53
2026-09-14$159M
2026-09-14$-0.26$14M
2026-09-14
2026-09-14$0.84$26M
2026-09-14

Price

Price$3.75
Market Cap$1M
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book0.23
EV / EBITDA0.15
Dividend Yield0.00%

Financial Health

Debt / Equity0.01
Current Ratio3.00
Piotroski F-Score2
Altman Z-Score-45.94

Related companies: CARM · GTBP · LIPO · PBM · PTIX · REVB · SLRX

Explore sector: Healthcare · Biotechnology

More sections of ARTL: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks